3.7(top 10%)
impact factor
14.9K(top 1%)
papers
437.4K(top 1%)
citations
173(top 2%)
h-index
3.8(top 10%)
impact factor
15.8K
all documents
501.2K
doc citations
247(top 2%)
g-index

Top Articles

#TitleJournalYearCitations
1Plasma inflammatory cytokines and chemokines in severe acute respiratory syndromeClinical and Experimental Immunology20041,084
2Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokinesClinical and Experimental Immunology1998935
3The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an updateClinical and Experimental Immunology2010899
4Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1? generationClinical and Experimental Immunology2006832
5Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)Clinical and Experimental Immunology2008824
6Enhand secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's diseaseClinical and Experimental Immunology2008789
7The paradox of matrix metalloproteinases in infectious diseaseClinical and Experimental Immunology2005783
8T cells in multiple sclerosis and experimental autoimmune encephalomyelitisClinical and Experimental Immunology2010761
9Macrophage activation switching: an asset for the resolution of inflammationClinical and Experimental Immunology2005696
10The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune diseaseClinical and Experimental Immunology2007632
11Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+ regulatory T cellsClinical and Experimental Immunology2009595
12Analysis of islet inflammation in human type 1 diabetesClinical and Experimental Immunology2009577
13Interferon-γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cellsClinical and Experimental Immunology2007559
14Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancyClinical and Experimental Immunology1996557
15Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humansClinical and Experimental Immunology1998537
16Inducible nitric oxide synthase in human diseasesClinical and Experimental Immunology1998510
17Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986Clinical and Experimental Immunology1987503
18Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalitiesClinical and Experimental Immunology2007480
19Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphismClinical and Experimental Immunology2008473
20Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestineClinical and Experimental Immunology2008427
21Elevated tumour necrosis factor-alpha (TNF-α) biological activity in psoriatic skin lesionsClinical and Experimental Immunology2008422
22Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of resultsClinical and Experimental Immunology1985418
23A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypesClinical and Experimental Immunology2003401
24The protective role of antibody responses duringMycobacterium tuberculosisinfectionClinical and Experimental Immunology2009394
25Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-γ , IL-4, IL-10 and IL-13) in patients with allergic asthmaClinical and Experimental Immunology2001385
26C1 inhibitor deficiency: consensus documentClinical and Experimental Immunology2005385
27Bacterial superantigensClinical and Experimental Immunology2003371
28Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogensClinical and Experimental Immunology1971371
29Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsiaClinical and Experimental Immunology1999364
30The number of human peripheral blood CD4+ CD25high regulatory T cells increases with ageClinical and Experimental Immunology2005359
31Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR)Clinical and Experimental Immunology2008356
32Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implicationsClinical and Experimental Immunology1966351
33Production of complement components by cells of the immune systemClinical and Experimental Immunology2017350
34Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitisClinical and Experimental Immunology1997347
35Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID)Clinical and Experimental Immunology2000338
36Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complexClinical and Experimental Immunology2009334
37The NLRP3 inflammasome in health and disease: the good, the bad and the uglyClinical and Experimental Immunology2011333
38Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironmentClinical and Experimental Immunology2012333
39Infections and immunodeficiency in Down syndromeClinical and Experimental Immunology2011332
40Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune systemClinical and Experimental Immunology2016332
41Extrahepatic complement biosynthesis: where, when and why?Clinical and Experimental Immunology1997331
42Reference values for B cell subpopulations from infancy to adulthoodClinical and Experimental Immunology2010330
43Ageing, tumour necrosis factor-alpha (TNF-α) and atherosclerosisClinical and Experimental Immunology2000328
44Network of immune-neuroendocrine interactionsClinical and Experimental Immunology1977325
45The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disordersClinical and Experimental Immunology2007324
46Immunopathogenic mechanisms in psoriasisClinical and Experimental Immunology2004323
47HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosisClinical and Experimental Immunology2008322
48The role of infections in autoimmune diseaseClinical and Experimental Immunology2008316
49Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2Clinical and Experimental Immunology2008313
50Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1qClinical and Experimental Immunology1976312